RecruitingPhase 2 / Phase 3NCT07204275
Renal
Primary membranous glomerulonephritis
20
studies recruiting now
as of 7 Sept 2026
53
studies registered in total
as of 7 Sept 2026
23
countries with a recruiting site
as of 7 Sept 2026
6 May 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT06962800
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
RecruitingPhase 2NCT07571746
A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
RecruitingPhase 2NCT06466135
Study of WAL0921 in Patients With Glomerular Kidney Diseases
RecruitingPhase 2NCT03949855
Belimumab With Rituximab for Primary Membranous Nephropathy
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 20 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Primary membranous glomerulonephritis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Primary membranous glomerulonephritis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).